Skip to main content
Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
6.70
-0.06 (-0.89%)
May 9, 2025, 11:14 AM - Market open

DAWN Revenue

Day One Biopharmaceuticals had revenue of $30.76M in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to $161.92M. In the year 2024, Day One Biopharmaceuticals had annual revenue of $131.16M.

Revenue (ttm)
$161.92M
Revenue Growth
n/a
P/S Ratio
4.06
Revenue / Employee
$894,597
Employees
181
Market Cap
679.13M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024131.16M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.98B
Novartis AG 53.22B
Eli Lilly and Company 49.00B
Novo Nordisk 43.92B
Revenue Rankings

DAWN News

More News